Dr J Rould
Full-Time Tech Investor, Quantum/Cybersecurity, Philosophy Background
Visa's roughly 30x earnings multiple and $750 billion valuation leave less upside than other opportunities, even if it keeps executing; the best case may be another doubling over a few years. Its once-impenetrable moat may look different in five years, while its reputation as a safe compounder is already priced in. This is a relative judgment, not a prediction that Visa cannot keep rising. x.com x.com x.com x.com x.comÂ
American Express's credit risk keeps its multiple below Visa's or Mastercard's, but that persistently low valuation lets management retire shares steadily. At 16x forward earnings it is not especially cheap by its own history; 28% of shares were retired over ten years. Buying here looks more like owning a steady cash-returning compounder than expecting extraordinary returns. x.comÂ
S&P Global, Mastercard, Visa, Moody's and Berkshire Hathaway have turned from portfolio ballast into funding shorts. These EPS compounders once pulled portfolios up alongside spicier longs, but they are never particularly cheap, Visa may rise only 4-5% on great earnings, and they can't be taken out. For most investors' horizons they are irrelevant next to momentum stocks that gap up 30% on narratives, so owning them now means being long funding shorts. That could change. x.com x.comÂ
Visa's volume and earnings growth show its network benefits from the global shift to digital payments. FY revenue rose 15% to $45.9B, adjusted EPS 16%, payments volume 9% and cross-border volume 13%. One of the world's highest-quality businesses, it is among the few most comfortable to hold for the next decade. Adjusted operating expenses rose 16%, ahead of revenue; client incentives rose 16% to $18.3B but threaten margins only if they get out of control. Regulation and litigation remain risks. … Show more
Mastercard's payment and earnings growth make it more satisfying than ever to own amid Alphabet's and Amazon's post-earnings reactions. Q3 2026 revenue rose 14% to $9.8 billion, adjusted EPS rose 21% to $5.31, and adjusted operating margin was 60.5%. Volume grew 7%, cross-border volume 11%, and $3.8 billion went to shareholders through buybacks and dividends. x.comÂ
Mastercard may be the only scaled, capital-light network benefiting from AI, with bloated technical debt uniquely addressable by coding tools. Nominal inflation-linked recurring revenues and hardware attach add to the case at low-teens free-cash-flow yields. While payments getting bid in a red market probably signals the rally is over, these traits could mean it is not. x.comÂ
Visa and Mastercard look like attractive, safe cash machines at decade-low valuations, likely compounding 10-15% a year from here. Mastercard trades at 23x forward earnings, its lowest in a decade, and Visa at 22x; Mastercard just bounced off its 200-week moving average, untouched since 2022. They will not 10x in ten years but should protect the downside. Visa is slightly preferred for its sheer size, though Mastercard grows faster. x.comÂ
American Express's continued growth makes its lower forward multiple than Mastercard and Visa a very attractive long-term opportunity. It trades at 16.7x forward earnings against more than 26x for each peer. All three sold off earlier this year, but Mastercard and Visa reached new highs while American Express remains down 15.6% year to date. x.comÂ
Visa could move lower if higher expenses keep compressing margins into Q4. Q3 beat on adjusted EPS ($3.32 vs $2.98 expected), net revenue (+14% to $11.6 billion) and payments volume (+10%), but operating expenses rose 19% to $4.76 billion against $4.0 billion expected. Q4 guidance calls for low-double-digit expense growth versus 8% expected and EPS growth at the low end of mid-teens versus 16%. It could drop like American Express last week if the call confirms margin compression continues. x.comÂ
Visa is a quality compounder whose stock has lagged its earnings. Over the last decade it grew EPS at more than twice the rate of its transaction volume. Over the past five years, EPS rose 138% while market cap rose only 40%, a big discrepancy for one of the greatest businesses on the planet. x.com x.com x.comÂ
FICO's moat is starting to get disrupted, and the premium multiple holders once defended has not held up. Two years ago the stock traded at 80x EPS on the argument that a high-quality compounder with a moat deserved it; that multiple has since compressed by about 80%. FICO would need to rise 280% to regain its all-time high, and there is a good chance it never does. x.com x.com x.comÂ
